A Q2 2022 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q2 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.6B+5.4% YoY

Gross Profit

$861M53.6% margin

Operating Income

$360M22.4% margin

Net Income

$274M17.1% margin

EPS (Diluted)

$0.91

QoQ Revenue Growth

-4.0%

Cash Flow

Operating Cash Flow

$283M

Free Cash Flow

$219M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$10.5B

Total Liabilities

$5.3B

Stockholders' Equity

$5.1B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.5B	+5.4%
Gross Profit	$861M	$817M	+5.4%
Operating Income	$360M	$288M	+25.0%
Net Income	$274M	$216M	+26.9%

Revenue Segments

Life Sciences and Applied Markets

$896M56%

Diagnostics and Genomics

$358M22%

Agilent CrossLab

$353M22%

Geographic Segments

Americas

$659M41%

Asia Pacific

$525M33%

Europe

$423M26%